Aliskiren suppresses the renin–angiotensin–aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension

References

• ImaiEHorioMIsekiKPrevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficientClin Exp Nephrol200711215616317593516
   PubMedGoogle Scholar
• CoreshJSelvinEStevensLAPrevalence of chronic kidney disease in the United StatesJAMA2007298172038204717986697
   PubMed Web of Science ®Google Scholar
• CoreshJAstorBCGreeneTEknoyanGLeveyASPrevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination SurveyAm J Kidney Dis200341111212500213
   PubMed Web of Science ®Google Scholar
• RitzEMinor renal dysfunction: an emerging independent cardiovascular risk factorHeart200389996396412922986
   PubMed Web of Science ®Google Scholar
• FerrarioCMStrawnWBRole of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular diseaseAm J Cardiol200698112112816784934
   PubMed Web of Science ®Google Scholar
• RusterCWolfGRenin-angiotensin-aldosterone system and progression of renal diseaseJ Am Soc Nephrol200617112985299117035613
   PubMed Web of Science ®Google Scholar
• RuggenentiPPernaARemuzziGACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in NephropathyJ Am Soc Nephrol200112122832283711729254
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGClarkeWRRenoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetesN Engl J Med20013451285186011565517
   PubMed Web of Science ®Google Scholar
• BerlTHunsickerLGLewisJBCardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyAnn Intern Med2003138754254912667024
   PubMed Web of Science ®Google Scholar
• BrennerBMCooperMEde ZeeuwDEffects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathyN Engl J Med20013451286186911565518
   PubMed Web of Science ®Google Scholar
• NussbergerJWuerznerGJensenCBrunnerHRAngiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalaprilHypertension2002391E1E811799102
   PubMed Web of Science ®Google Scholar
• ItoSNakuraNLe BretonSKeefeDEfficacy and safety of aliskiren in Japanese hypertensive patients with renal dysfunctionHypertens Res2010331626619927154
   PubMed Web of Science ®Google Scholar
• PerssonFRossingPSchjoedtKJTime course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetesKidney Int200873121419142518337712
   PubMed Web of Science ®Google Scholar
• MorishitaYHanawaSChindaJIimuraOTsunematsuSKusanoEEffects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertensionHypertens Res201134330831321124333
   PubMed Web of Science ®Google Scholar
• ParvingHHPerssonFLewisJBLewisEJHollenbergNKAliskiren combined with losartan in type 2 diabetes and nephropathyN Engl J Med2008358232433244618525041
   PubMed Web of Science ®Google Scholar
• McMurrayJJPittBLatiniREffects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failureCirc Heart Fail200811172419808266
   PubMed Web of Science ®Google Scholar
• MatsuoSImaiEHorioMRevised equations for estimated GFR from serum creatinine in JapanAm J Kidney Dis200953698299219339088
   PubMed Web of Science ®Google Scholar
• RodbardDStatistical quality control and routine data processing for radioimmunoassays and immunoradiometric assaysClin Chem19742010125512704370388
   PubMed Web of Science ®Google Scholar
• EmanuelRLCainJPWilliamsGHDouble antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasmaJ Lab Clin Med19738146326404348744
   PubMed Web of Science ®Google Scholar
• BeckettNSPetersRFletcherAETreatment of hypertension in patients 80 years of age or olderN Engl J Med2008358181887189818378519
   PubMed Web of Science ®Google Scholar
• YoungJHKlagMJMuntnerPWhyteJLPahorMCoreshJBlood pressure and decline in kidney function: findings from the Systolic Hypertension in the Elderly Program (SHEP)J Am Soc Nephrol200213112776278212397049
   PubMed Web of Science ®Google Scholar
• OkadaTNakaoTMatsumotoHPrognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney diseaseHypertens Res200932121123112919816503
   PubMed Web of Science ®Google Scholar
• HenryRMKostensePJBosGMild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn StudyKidney Int20026241402140712234312
   PubMed Web of Science ®Google Scholar
• IshaniAGranditsGAGrimmRHAssociation of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trialJ Am Soc Nephrol20061751444145216611715
   PubMed Web of Science ®Google Scholar
• HalbesmaNKuikenDSBrantsmaAHMacroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screeningJ Am Soc Nephrol20061792582259016899519
   PubMed Web of Science ®Google Scholar
• TonelliMJosePCurhanGSacksFBraunwaldEPfefferMProteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trialBMJ20063327555142616714328
   PubMed Web of Science ®Google Scholar
• LatiniRMassonSAnandIThe comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFTEur Heart J200425429229914984917
   PubMed Web of Science ®Google Scholar
• JourdainPJondeauGFunckFPlasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter StudyJ Am Coll Cardiol200749161733173917448376
   PubMed Web of Science ®Google Scholar
• SchmiederREPhilippTGuerediagaJLong-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazideCirculation2009119341742519139391
   PubMed Web of Science ®Google Scholar